Amgen (AMGN) Capital Expenditures (2009 - 2026)
Amgen (AMGN) posted Capital Expenditures of $513 million for Q2 2026, up 39.0% from $369 million a year earlier but down 27.9% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Capital Expenditures (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Amgen was $2.3 billion, up 63.6% year-over-year; for FY2025, it came in at $1.86 billion, up 69.5% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 25.0% (FY2020 to FY2025).
- In prior years, Amgen's Capital Expenditures was $1.1 billion in FY2024 (-1.4%), $1.11 billion in FY2023 (+18.8%), $936 million in FY2022 (+6.4%) and $880 million in FY2021 (+44.7%).
- Quarterly Capital Expenditures has run from a low of $160 million in Q3 2022 to a high of $712 million in Q1 2026 over five years.
- On a year-over-year basis, Capital Expenditures has increased in each of the last eight quarters, with growth averaging 55.2% over the last eight quarters.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2023, with growth of 81.1%; the weakest was Q3 2022, with a decline of 33.9%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $712 million (Q1 2026), $642 million (Q4 2025) and $436 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 305.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 513.00 Mn |
| Mar 31, 2026 | 712.00 Mn |
| Dec 31, 2025 | 642.00 Mn |
| Sep 30, 2025 | 436.00 Mn |
| Jun 30, 2025 | 369.00 Mn |
| Mar 31, 2025 | 411.00 Mn |
| Dec 31, 2024 | 371.00 Mn |
| Sep 30, 2024 | 257.00 Mn |
| Jun 30, 2024 | 238.00 Mn |
| Mar 31, 2024 | 230.00 Mn |
| Dec 31, 2023 | 249.00 Mn |
| Sep 30, 2023 | 248.00 Mn |
| Jun 30, 2023 | 271.00 Mn |
| Mar 31, 2023 | 344.00 Mn |
| Dec 31, 2022 | 340.00 Mn |
| Sep 30, 2022 | 160.00 Mn |
| Jun 30, 2022 | 246.00 Mn |
| Mar 31, 2022 | 190.00 Mn |
| Dec 31, 2021 | 287.00 Mn |
| Sep 30, 2021 | 242.00 Mn |
API Access
Amgen Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();